产前阿片类药物暴露后新生儿结果的性别差异
Nethra K Madurai1, Lauren L Jantzie1,2,3,4, Elizabeth Yen5,6,7
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Frontiers in pediatrics
|April 5, 2024
概括
产前阿片类药物暴露会影响新生儿,而生物性别会影响结果. 需要进行研究,以了解性别特异性对婴儿大脑发育和健康的影响.
科学领域:
- 新生儿结局的结果.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 阿片类药物流行病构成了重大的公共卫生挑战,影响到孕妇和婴儿.
- 了解阿片类药物在怀孕期间和产后对大脑发育的影响至关重要.
- 生物性别是生理过程的关键因素,可能会影响阿片类药物暴露的婴儿的新生儿结果.
研究的目的:
- 审查关于生物性别对产前阿片类药物暴露后新生儿结果的影响的当前文献.
- 强调在新生儿研究中将性别视为生物变量的重要性.
- 为改善产前阿片类药物暴露影响的婴儿健康的策略提供信息.
主要方法:
- 对调查新生儿结局与产前阿片类药物暴露有关的性别差异的研究进行文献综述.
- 对婴儿性别特异性影响的新兴临床数据的分析.
- 综合了关于基因表达,养调节,奖励通路和白质损伤的发现.
主要成果:
- 在成年人中,阿片类药物使用障碍的性别差异已经确立,但在新生儿中理解程度较低.
- 新出现的数据表明婴儿的性别特异性影响,包括对调节养和奖励通路的基因的影响.
- 在产前暴露于阿片类药物的女婴可能会增加对白质损伤的敏感性.
结论:
- 生物性别显著影响产前阿片类药物暴露后新生儿的结果.
- 对性别特异性影响的进一步研究对于有针对性的干预和改善婴儿健康至关重要.
- 了解这些性别差异对于解决受阿片类药物流行影响的个人长期健康问题至关重要.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Opioid Analgesics: Morphine and Other Natural Cogeners
244
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
244
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614


